-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Iovance Biotherapeutics, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate for 2023.
- Iovance Biotherapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending September 30, 2024 was $58.6M, a 12385% increase year-over-year.